Does Surgeon (Instead of Operator) Experience Affect TAVR?

There is a correlation between the volume of conventional surgical aortic valve replacement procedures and better outcomes in transcatheter aortic valve replacement (TAVR), with higher 30-day and 1-year mortality in sites with lower volume. This is a probable indication that a good surgical team is complemented by a good hemodynamic team and, ultimately, a good heart team that carefully selects which patients will be assigned to each strategy.

Experiencia de los cirujanos

Additionally, there is much evidence indicating that interventional cardiologist experience has a significant impact on outcomes. This work solidifies our understanding that the whole team’s experience (and not only individual operator experience) is important.

Researchers assessed 208,400 patients who underwent heart surgery from 2012 to 2015. Sites were classified according to the volume of surgeries during the study period. The primary endpoint was mortality at 30 days and at 1 year after TAVR.

A total of 65,757 patients underwent surgical valve replacement and 42,967 underwent TAVR. Among TAVR procedures, 21.7% (n = 9324) were performed at hospitals with <100 surgeries per year, 35.6% at sites with 100 to 199 surgeries, 22.9% at sites with 200 to 299, and 19.8% at hospitals with over 300 surgical aortic valve replacement procedures per year.


Read also: ACC 2020 Virtual | PRECOMBAT: 10 años para cirugía vs angioplastia en el tronco de la coronaria izquierda.


Mortality at 30 days was 30% higher in sites with <100 surgeries and 25% in sites with 100 to 199 surgeries, compared with sites with >300 surgeries (odds ratio [OR]: 1.32; 95% confidence interval [CI]: 1.18 to 1.47, and OR: 1.25; 95% CI: 1.12 to 1.39, respectively). The difference in relation to sites with 200 to 299 surgeries was not significant.

The aforementioned differences persisted one year after TAVR.

Conclusion

The total volume of surgical aortic valve replacement procedures at a site is well correlated with TAVR outcomes for the same site. Sites with <100 surgeries per year have the highest mortality rate with TAVR. These data support the notion that surgical programs go hand in hand with TAVR programs, and that a minimum of surgical procedures should be considered as an additional metric for TAVR outcomes.

Original title: Relationship Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes.

Reference: Sameer A. Hirji et al. J Am Coll Cardiol Intv 2020;13:335–43.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...